Dermsquared Scheduled Maintenance, Thursday Feb 29, 6:30am to 8:30am EST

Live Evaluations

Advancing Acne Care with Topical Combination Therapy: What Does the Future Hold?

About

Advancing Acne Care with Topical Combination Therapy: What Does the Future Hold?

This activity is supported by an educational grant from Ortho Dermatologics.

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Discuss the role of topical combination therapies for the management of acne

  • Describe how to select triple combination therapy for the management of acne

  • Sketch strategies to talk to patients about triple combination therapy for the management of acne

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Boni
Boni Elewski, MD

James Elder Professor and Chair of Dermatology
University of Alabama at Birmingham
Birmingham, AL

Linda
Linda Stein Gold, MD

Director Clinical Research 
Henry Ford Health System 
Detroit, MI

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Boni E. Elewski, MD

Grant/Research Support: Ortho Dermatology

Consultant: Ortho Dermatology 

Linda F. Stein Gold, MD

Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie

Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie

Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved